NEW YORK (GenomeWeb) – Epigenomics on Thursday lowered its revenue guidance for 2017 to a range of between €1 million ($1.1 million) and €1.5 million from a previous guidance of about €2.5 million.

The firm attributed the change to lower-than-expected revenues for the first half of the year, about €500,000, and added that it anticipates a continued lack of reimbursement coverage for the rest of the year in the US. In May the firm reported a 5 percent drop in revenues for the first quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.